Effect of Surgery on Cardiovascular Risk Factors in Mild Primary Hyperparathyroidism
Author(s) -
Jens Bollerslev,
Thord Rosén,
Charlotte Mollerup,
Jörgen Nordenström,
M Baranowski,
Celina Franco,
Ylva Pernow,
Gunhild A. Isaksen,
Kristin Godang,
Thor Ueland,
Svante Jansson
Publication year - 2009
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2008-2742
Subject(s) - medicine , insulin resistance , primary hyperparathyroidism , adipokine , bone remodeling , metabolic syndrome , endocrinology , blood pressure , randomized controlled trial , gastroenterology , lipid profile , surgery , insulin , obesity , cholesterol
Mild primary hyperparathyroidism (pHPT) seems to have a good prognosis, and indications for active treatment (surgery) are widely discussed. The extraskeletal effects of PTH, such as insulin resistance, arterial hypertension, and cardiovascular (CV) risk, may however be reversible by operation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom